OpportunityTitle: Rigorous Evaluation of Primary and Secondary Overdose Prevention Activities Among Populations Disproportionately Affected by Overdose
AdditionalInformationOnEligibility: The following types of Higher Education Institutions are encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Nonprofits (Other than Institutions of Higher Education); Faith-based or Community-based Organizations; Regional Organizations; Bona Fide Agents: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with &#8220;Other Attachment Forms;&#8221; Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency&apos;s existing in-house or contractor resources. FFRDC&apos;s enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://gov.ecfr.io/cgi-bin/searchECFR.
Description: This NOFO funds research focused on people experiencing disproportionate burden of drug overdose, those who are at greater risk of exposure to drug use, or those experiencing adverse drug use outcomes related to social determinants of health. Your research should rigorously evaluate either primary or secondary prevention strategies for reducing rates of nonfatal overdose, fatal overdose, and/or substance use disorders involving federally illegal drugs or misuse of prescription medications, drug use, or initiation of drug use, particularly among youth.
GrantorContactEmailDescription: ncipc_erpo@cdc.gov
GrantorContactText: Candis M. Hunter, PhD, MSPH, REHS&lt;br/&gt;ncipc_erpo@cdc.gov
CloseDateExplanation: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.